| abstract |
A liquid preparation containing a recombinant monoclonal antibody containing 10 mg / mL to 200 mg / mL, a 45 mM to 94 mM amino acid component having a histidine component of less than 5 mM, and a pH of 5.5 to 7.0. The present invention provides a stable recombinant monoclonal antibody liquid preparation that achieves at least one of suppression of dimer formation, degradation product formation, reduction of biological activity and suppression of deamidation during long-term storage. |